Agenzia Italiana del Farmaco
Hepatitis C: update of 25 July 2022 concerning enrolled patients - Hepatitis C: update of 25 July 2022 concerning enrolled patients
Hepatitis C: update of 25 July 2022 concerning enrolled patients
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
The information is contained in the page "Update on hepatitis C" accessible through the box "Related links".
Published on: 25 July 2022